Mesothelioma Applied Research Foundation to Fund Additional Studies

Though the nation and world are intensely focused on the COVID-19 crisis and finding effective treatments and vaccines, that in no way diminishes the need for continued attention to other challenging illnesses, including malignant mesothelioma. In recognition of the need for innovative new treatments, the Mesothelioma Applied Research Foundation recently announced a continuation of its support of research on this fatal, asbestos-related cancer. The organization will be funding three separate and deserving research projects.

$300,000 Allocated for Three Separate Mesothelioma Research Projects

Speaking of the need for more effective treatment options for patients diagnosed with malignant mesothelioma, nurse practitioner and Executive Director of the Meso Foundation Mary Hesdorffer said, “We are keenly aware that mesothelioma patients still need effective treatments, first and foremost. We are deeply grateful to all of our donors and supporters who made this funding possible with their financial contributions.”

Earlier in the year, the Mesothelioma Applied Research Foundation joined with other charitable organizations that requested that Congressional leaders recognize the challenges of fundraising during the COVID-19 crisis. The group asked that Congress continue funding medical research. The newly announced investment from the 501(c)(3) non-profit totals $300,000, bringing the Meso Foundation’s funding total to $10.5 million since it began in the year 2000.

Choosing Worthy Mesothelioma Research

The Meso Foundation follows a robust selection process supported by experts in the field of mesothelioma research. Their goal is to fund the most promising studies, reviewing all applications for grants and ranking them through an unbiased peer-review process. The amount of funding available determines the number of projects that will be funded.

The three projects selected were chosen from nearly 50 applications that were narrowed down to eight finalists. Though all three that were selected for funding will examine the impact of immunotherapy on mesothelioma patients, each takes a different approach.

As scientists work to find effective treatments for malignant mesothelioma, the Patient Advocates at are working to support those who are currently afflicted with the disease. For more information on the resources available to you, contact us today at 1-800-692-8608.

Terri Heimann Oppenheimer

Terri Oppenheimer

Terri Heimann Oppenheimer is the head writer of our news blog. She graduated from the College of William and Mary with a degree in English. Terri believes that knowledge is power and she is committed to sharing news about the impact of mesothelioma, the latest research and medical breakthroughs, and victims’ stories.

Learn More About And Contact Terri
Get Help Contacting
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now